Goldman Sachs Downgrades Myriad Genetics (MYGN) to Neutral Following SCOTUS Case

Go back to Goldman Sachs Downgrades Myriad Genetics (MYGN) to Neutral Following SCOTUS Case
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 3.03 +0.16 (5.57%)
Previous Close $2.87    52 Week High $45.34 
Open $2.95    52 Week Low $15.92 
Day High $3.05    P/E 1.30 
Day Low $2.92    EPS $2.33 
Volume 287,290